{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:31:56Z","timestamp":1790821916306,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jprot.2012.09.022","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T21:35:48Z","timestamp":1348868148000},"page":"26-33","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Characterization of \u03b1-l-Iduronidase (Aldurazyme\u00ae) and its complexes"],"prefix":"10.1016","volume":"80","author":[{"given":"Gangsoo","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Lubec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2012.09.022_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"issue":"Suppl. 5","key":"10.1016\/j.jprot.2012.09.022_bb0010","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jprot.2012.09.022_bb0015","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3421","article-title":"The mucopolysaccharides","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.jprot.2012.09.022_bb0020","doi-asserted-by":"crossref","first-page":"471325","DOI":"10.1155\/2012\/471325","article-title":"Glycosaminoglycan storage disorders: a review","volume":"2012","author":"Coutinho","year":"2012","journal-title":"Biochem Res Int"},{"key":"10.1016\/j.jprot.2012.09.022_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1010379320378","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties","volume":"24","author":"Wraith","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jprot.2012.09.022_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1440-1673.1986.tb02408.x","article-title":"A further contribution to the knowledge of mucopolysaccharidosis I H\/S compound. Presentation of two cases and review of the literature","volume":"30","author":"Colavita","year":"1986","journal-title":"Australas Radiol"},{"key":"10.1016\/j.jprot.2012.09.022_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajmg.1320200308","article-title":"The clinical spectrum of alpha-l-iduronidase deficiency","volume":"20","author":"Roubicek","year":"1985","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jprot.2012.09.022_bb0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jprot.2012.09.022_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"Enzyme replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"Kakkis","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jprot.2012.09.022_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2009.12.019","article-title":"Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase","volume":"100","author":"Valayannopoulos","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jprot.2012.09.022_bb0055","doi-asserted-by":"crossref","first-page":"22758","DOI":"10.1074\/jbc.272.36.22758","article-title":"Carbohydrate structures of recombinant human alpha-l-iduronidase secreted by Chinese hamster ovary cells","volume":"272","author":"Zhao","year":"1997","journal-title":"J Biol Chem"},{"issue":"Suppl. 6","key":"10.1016\/j.jprot.2012.09.022_bb0060","doi-asserted-by":"crossref","first-page":"vi 3","DOI":"10.1093\/ndt\/gfh1092","article-title":"Factors influencing the immunogenicity of therapeutic proteins","volume":"20","author":"Schellekens","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jprot.2012.09.022_bb0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4161\/mabs.3.6.17611","article-title":"Aggregation, immune complexes and immunogenicity","volume":"3","author":"Jefferis","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.jprot.2012.09.022_bb0070","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1023\/A:1015929109894","article-title":"Stability of protein pharmaceuticals","volume":"6","author":"Manning","year":"1989","journal-title":"Pharm Res"},{"key":"10.1016\/j.jprot.2012.09.022_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tips.2009.11.001","article-title":"Immunological mechanism underlying the immune response to recombinant human protein therapeutics","volume":"31","author":"Sauerborn","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jprot.2012.09.022_bb0080","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2012.09.022_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jprot.2012.09.022_bb0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00726-007-0613-1","article-title":"Identification and characterisation of arsenite (+3 oxidation state) methyltransferase (AS3MT) in mouse neuroblastoma cell line N1E-115","volume":"35","author":"John","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.jprot.2012.09.022_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nprot.2009.92","article-title":"Gel-based mass spectrometric analysis of a strongly hydrophobic GABAA-receptor subunit containing four transmembrane domains","volume":"4","author":"Kang","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jprot.2012.09.022_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pmic.200900624","article-title":"Silk cocoon of Bombyx mori: proteins and posttranslational modifications\u2013heavy phosphorylation and evidence for lysine-mediated cross links","volume":"10","author":"Chen","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2012.09.022_bb0105","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/ac070363i","article-title":"Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans","volume":"79","author":"Pabst","year":"2007","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2012.09.022_bb0110","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1021\/ac101975k","article-title":"Nucleotide and nucleotide sugar analysis by liquid chromatography-electrospray ionization-mass spectrometry on surface-conditioned porous graphitic carbon","volume":"82","author":"Pabst","year":"2010","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2012.09.022_bb0115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00726-010-0542-2","article-title":"Purification of recombinant growth hormone by clear native gels for conformational analyses: preservation of conformation and receptor binding","volume":"39","author":"Chen","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.jprot.2012.09.022_bb0120","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1021\/pr201099u","article-title":"Keihan Falsafi S, Russo-Schlaff N, Pollak A, Lubec G. Mass spectrometrical identification of hippocampal NMDA receptor subunits NR1, NR2A-D and five novel phosphorylation sites on NR2A and NR2B","volume":"11","author":"Ghafari","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2012.09.022_bb0125","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1016\/S0021-9258(19)68669-2","article-title":"The mannose 6-phosphate receptor of Chinese hamster ovary cells. Compartmentalization of acid hydrolases in mutants with altered receptors","volume":"256","author":"Robbins","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jprot.2012.09.022_bb0130","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1248\/bpb.31.1691","article-title":"Uptake of a recombinant human alpha-l-iduronidase (laronidase) by cultured fibroblasts and osteoblasts","volume":"31","author":"Tsukimura","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jprot.2012.09.022_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.20081","article-title":"Identification and molecular characterization of alpha-l-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy","volume":"24","author":"Yogalingam","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jprot.2012.09.022_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-1033.1985.tb09158.x","article-title":"Human alpha-l-iduronidase. Purification, monoclonal antibody production, native and subunit molecular mass","volume":"152","author":"Clements","year":"1985","journal-title":"Eur J Biochem"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391912006665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391912006665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T18:44:36Z","timestamp":1643481876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391912006665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":28,"alternative-id":["S1874391912006665"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2012.09.022","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}